HCM
BLACR
Highbridge Capital Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-836,469
| Closed | -$100K | – | 329 |
|
|
2024
Q4 | $100K | Hold |
836,469
| – | – | ﹤0.01% | 202 |
|
|
2024
Q3 | $87.2K | Hold |
836,469
| – | – | ﹤0.01% | 199 |
|
|
2024
Q2 | $92.9K | Hold |
836,469
| – | – | ﹤0.01% | 185 |
|
|
2024
Q1 | $125K | Hold |
836,469
| – | – | ﹤0.01% | 160 |
|
|
2023
Q4 | $125K | Buy |
836,469
+100,000
| +14% | +$15K | 0.01% | 139 |
|
|
2023
Q3 | $206K | Hold |
736,469
| – | – | 0.01% | 165 |
|
|
2023
Q2 | $169K | Buy |
736,469
+160,000
| +28% | +$36.8K | 0.01% | 170 |
|
|
2023
Q1 | $104K | Buy |
+576,469
| New | +$104K | ﹤0.01% | 232 |
|